AMB-CHMINACA

AMB-CHMINACA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate;
CAS Number	1863066-03-8(racemate);
PubChem CID	119026010;
ChemSpider	32055578;
UNII	OU56JJP891; Y21A13WADY(racemate);
CompTox Dashboard (EPA)	DTXSID601344891 ;
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.481 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O;
	InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1; Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N;

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid^[1] that is a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[2]^[3]^[4]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.^[5]

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.^[6]

References

^ Akamatsu S, Yoshida M (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. Bibcode:2016JMSp...51...28A. doi:10.1002/jms.3722. PMID 26757069.
^ "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.
^ "MA-CHMINACA". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 21 July 2015.
^ Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, et al. (September 2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7 (9): 1241–54. doi:10.1021/acschemneuro.6b00137. PMID 27421060.
^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Archived from the original on 15 July 2015. Retrieved 21 July 2015.
^ "Sexton nya ämnen klassas som narkotika eller hälsofarlig vara" [Sixteen new substances classified as narcotics or dangerous to health] (in Swedish). Folkhälsomyndigheten. 18 January 2019. Archived from the original on 3 June 2021. Retrieved 11 November 2019.

[1] Akamatsu S, Yoshida M (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. Bibcode:2016JMSp...51...28A. doi:10.1002/jms.3722. PMID 26757069.

[2] "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.

[3] "MA-CHMINACA". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 21 July 2015.

[4] Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, et al. (September 2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7 (9): 1241–54. doi:10.1021/acschemneuro.6b00137. PMID 27421060.

[5] "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Archived from the original on 15 July 2015. Retrieved 21 July 2015.

[6] "Sexton nya ämnen klassas som narkotika eller hälsofarlig vara" [Sixteen new substances classified as narcotics or dangerous to health] (in Swedish). Folkhälsomyndigheten. 18 January 2019. Archived from the original on 3 June 2021. Retrieved 11 November 2019.

[1]

[2]

[3]

[4]

[5]

[6]

Legal status

See also

References